Magnus Höök

Title: Innovations by Magnus Hööök

Introduction

Magnus Hööök is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods related to fibronectin and collagen binding proteins. With a total of 2 patents, his work has implications for vaccine development and therapeutic applications.

Latest Patents

Hööök's latest patents include "Fibronectin binding protein compositions and methods of use" and "Collagen binding protein compositions and methods of use." The first patent discloses antibodies that block the binding of fibronectin protein to fibronectin. It also details site specifically-mutated and truncated peptide epitopes derived from the fnbA, fnbB, and sfb genes, along with nucleic acid segments encoding these peptides. These innovations are aimed at various applications, including active and passive immunization and methods for preventing streptococcal and staphylococcal colonization in humans and animals. The second patent focuses on the cna gene and cna-derived nucleic acid segments, proposing their use in preventing bacterial adhesion and infections, particularly in humans.

Career Highlights

Hööök has worked with the Texas A&M University System, where he has contributed to research and development in his field. His work has been instrumental in advancing the understanding of bacterial interactions and potential therapeutic interventions.

Collaborations

Some of his notable coworkers include Joseph M. Patti and Karen L. House-Pompeo. Their collaborative efforts have furthered research in the areas of immunology and infectious diseases.

Conclusion

Magnus Hööök's innovative work in biotechnology, particularly in the development of fibronectin and collagen binding protein compositions, showcases his significant contributions to the field. His patents hold promise for advancing vaccine formulations and therapeutic strategies against bacterial infections.